Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<IPO>Vaccine Firm Ab&B Bio-Tech Passes HK Listing Hearing
Recommend 13 Positive 18 Negative 12 |
||||
|
||||
|
Ab&B Bio-Tech has recently passed the listing hearing on the Hong Kong Stock Exchange, with CITIC Securities and CMBI acting as its joint sponsors. According to preliminary information after the hearing, Ab&B Bio-Tech was founded in 2015. It is a China-based vaccine manufacturer. For 1Q ended March 2025, it recorded a revenue of RMB413,000, up nearly 35% YoY, but its loss reached RMB87.317 million during the period, expanding from a loss of RMB63.331 million in the same period of 2024. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
